How much funding has Hearables 3D raised?

Hearables 3D has raised $6.8M in total funding. Key investors include Significant Ventures (lead), Swinburne University, Co:Act Capital.

Who is the CEO of Hearables 3D?

Iain McLeod is the CEO of Hearables 3D. The company was founded in 2018.

Where is Hearables 3D located?

Hearables 3D is headquartered in Melbourne, Australia.

What funding stage is Hearables 3D at?

Hearables 3D is currently at the Active stage.

How many employees does Hearables 3D have?

Hearables 3D has approximately 11-50 employees.

Hearables 3D

Name: AM Companies Database
Creator: AMPulse
License: https://creativecommons.org/licenses/by/4.0/

SoftwareMelbourne, AustraliaFounded 2018· One of 350 Software companies tracked by AMPulse

AI CAD automation software for custom-fit hearing and dental devices using smartphone scanning

CEO / Founder: Iain McLeod
Team Size: 11-50
Stage: Active
Total Funding: $6.8M
Latest Round: Series A
Key Investors: Significant Ventures (lead), Swinburne University, Co:Act Capital

Technology & Products

Key Products

AutoDesign Dental (AI Splints, Trays, Models), AutoDesign Audio (Earmoulds, Hearing Protection, IEMs, ITE Shells), Smartphone Scanning iOS libraries

Technological Advantage

AI-powered CAD automation (AutoDesign), smartphone 3D scanning libraries, cloud-based processing, no skilled CAD technicians required

Differentiation

Value Proposition

AI-powered CAD automation platform that enables labs to scale custom-fit hearing and dental device production without skilled technicians

How They Differentiate

AI automates entire CAD design process (no skilled technicians), smartphone scanning eliminates physical impressions, scalable B2B software platform

Market & Competition

Target Customers

Audiologists, Hearing aid manufacturers, Earphone brands

Industry Verticals

Audiology, Dental, Medical Devices, Consumer Audio

Competitors

Sonova, Starkey, Traditional impression-based manufacturers

Growth & Milestones

Growth Metrics

{"funding": "$6.8M", "offices": "Australia, Ireland, Denmark, France", "team_size": "11-50", "earpieces_processed": "millions", "dental_cases": "hundreds per minute"}

Major Milestones

2025: $5.8M Series A funding led by Significant Ventures with Swinburne University and Co:Act Capital; 2025: Official expansion into dental industry with AutoDesign Dental; Millions of devices produced; Offices in Melbourne, Copenhagen, Paris, Dublin; Partnerships with Rapid Shape, GN Hearing, ACS Custom, NASCAR

Notable Customers

Sennheiser, Dreve, Formlabs, GN Hearing Australia, ACS Custom, NASCAR, Andent, DentalSyd

https://h3d.ai

Why this company matters

Hearables 3D is an Australian service provider that replaces traditional silicone ear impressions with a smartphone-based 3D scanning workflow. The company targets audiologists, hearing aid manufacturers, and consumer audio brands, offering a digital pipeline from scan to finished device in under one hour using VPP-SLA printing.

The core technology combines proprietary smartphone ear scanning, automated CAD modeling, and ultra-fast SLA printing. This eliminates the need for physical impressions and reduces turnaround time from days to less than an hour. The company has processed over one million custom earpieces and expanded into dental care with an automated CAD service launched in 2024.

Hearables 3D serves the audiology, medical device, and consumer electronics verticals. Named partners include the UK's largest earmold manufacturer Minerva Labs, the NHS, Specsavers, Amplifon, and consumer audio brands Bose and Sennheiser. The company has raised $6.8 million from Swinburne Ventures and Significant Ventures, with offices in Australia, Ireland, and Denmark.

The company's main competitive advantage is its smartphone-based scanning workflow, which bypasses the need for in-person impression taking and enables rapid production. Competitors include traditional impression-based manufacturers and hearing aid incumbents like Sonova and Starkey. The key open question is whether the smartphone scanning accuracy meets the clinical standards required for medical-grade hearing devices across all patient populations.